COMP <GO>
LQDA vs JNJ // DIVIDEND YIELD & FCF PAYOUT SAFETY
Liquidia Corporation (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: LQDA 4
— JNJ 9
■ METRIC PARITY
LAST: $45.06 (+0.16%) • MKT CAP: $4.03B
dividend-safety
0.00%
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LQDA VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LQDA | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 67.90% | -26.90 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -12.60% | 25.50% | -38.10 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.99% | 2.97% | -3.96 | JNJ | /fcf-yield <GO> |
| Operating Margin | -32.50% | 34.70% | -67.20 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -43.50% | 28.50% | -72.00 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | 6.00% | +174.00 | LQDA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.33 | 5.59 | +0.74 | LQDA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 7.20% | -0.60 | LQDA | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.5 | 60.4 | -7.82 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 1.08 | -0.18 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.0x | 23.0x | -2.00 | LQDA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.03B | $662.49B | -$658.46B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LQDA REV | JNJ REV | LQDA GROSS % | JNJ GROSS % | LQDA FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $158.3M | $94.19B | 44.0% | 67.9% | -$40.0M | $19.70B |
| FY 2024 | $14.0M | $88.82B | 58.0% | 69.1% | -$98.4M | $19.84B |
| FY 2023 | $17.5M | $85.16B | 44.0% | 44.0% | -$42.4M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LQDA // BETA 0.90
JNJ // BETA 1.08